Abstract
We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine. Development of angioimmunoblastic lymphadenopathy although rare, is a very serious side effect of sulfasalazine treatment, and patients treated with this drug should be watched carefully.
MeSH terms
-
Adult
-
Antirheumatic Agents / adverse effects*
-
Arthritis, Juvenile / complications*
-
Arthritis, Juvenile / drug therapy
-
Arthritis, Juvenile / pathology
-
Chloroquine / toxicity
-
Humans
-
Immunoblastic Lymphadenopathy / chemically induced*
-
Immunoblastic Lymphadenopathy / drug therapy
-
Immunoblastic Lymphadenopathy / pathology
-
Lymph Nodes / pathology
-
Male
-
Methotrexate / therapeutic use
-
Methylprednisolone / therapeutic use
-
Sulfasalazine / adverse effects*
Substances
-
Antirheumatic Agents
-
Sulfasalazine
-
Chloroquine
-
Methylprednisolone
-
Methotrexate